ITRM20130138A1 - Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica - Google Patents

Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica

Info

Publication number
ITRM20130138A1
ITRM20130138A1 IT000138A ITRM20130138A ITRM20130138A1 IT RM20130138 A1 ITRM20130138 A1 IT RM20130138A1 IT 000138 A IT000138 A IT 000138A IT RM20130138 A ITRM20130138 A IT RM20130138A IT RM20130138 A1 ITRM20130138 A1 IT RM20130138A1
Authority
IT
Italy
Prior art keywords
entitlely
dive
neighbor
tied
inhibitor
Prior art date
Application number
IT000138A
Other languages
English (en)
Inventor
Sergio Capaccioli
Fabrizio Carta
Sonia Centi
Ratto Fulvio
Franco Fusi
Roberto Pini
Andrea Scozzafava
Claudiu T Supuran
Francesca Tatini
Ewa Janina Witort
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Priority to IT000138A priority Critical patent/ITRM20130138A1/it
Priority to EP14714382.0A priority patent/EP2964272A2/en
Priority to US14/773,046 priority patent/US20160015661A1/en
Priority to PCT/IB2014/059490 priority patent/WO2014136076A2/en
Publication of ITRM20130138A1 publication Critical patent/ITRM20130138A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/221—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by the targeting agent or modifying agent linked to the acoustically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0625—Warming the body, e.g. hyperthermia treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
IT000138A 2013-03-07 2013-03-07 Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica ITRM20130138A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT000138A ITRM20130138A1 (it) 2013-03-07 2013-03-07 Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica
EP14714382.0A EP2964272A2 (en) 2013-03-07 2014-03-06 Assembly comprising an absorber of near infrared (nir) light covalently linked to an inhibitor of carbonic anhydrase
US14/773,046 US20160015661A1 (en) 2013-03-07 2014-03-06 Assembly comprising an absorber of near infrared (nir) light covalently linked to an inhibitor of carbonic anhydrase
PCT/IB2014/059490 WO2014136076A2 (en) 2013-03-07 2014-03-06 Assembly comprising an absorber of near infrared (nir) light covalently linked to an inhibitor of carbonic anhydrase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000138A ITRM20130138A1 (it) 2013-03-07 2013-03-07 Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica

Publications (1)

Publication Number Publication Date
ITRM20130138A1 true ITRM20130138A1 (it) 2014-09-08

Family

ID=48227456

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000138A ITRM20130138A1 (it) 2013-03-07 2013-03-07 Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica

Country Status (4)

Country Link
US (1) US20160015661A1 (it)
EP (1) EP2964272A2 (it)
IT (1) ITRM20130138A1 (it)
WO (1) WO2014136076A2 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104623657B (zh) * 2014-12-25 2017-07-11 哈尔滨工程大学 一种应用于光动力治疗的纳米复合材料及其制备方法
CN105535972B (zh) * 2015-12-23 2018-10-16 中国科学院长春应用化学研究所 一种c3n4纳米复合材料、制备方法及其应用
JP7285537B2 (ja) 2016-03-16 2023-06-02 オン ターゲット ラボラトリーズ エルエルシー Ｃａ ｉｘ標的ｎｉｒ色素及びそれらの使用
US20200338211A1 (en) * 2017-12-29 2020-10-29 Wayne State University Method of treatment for solid tumors containing hypoxia and/or stroma features
CN108467469A (zh) * 2018-01-24 2018-08-31 北京服装学院 一种光热转换聚氨酯储能薄膜材料及其制备方法和薄膜
CN111166882B (zh) * 2020-01-13 2021-09-07 山东大学 酞菁-rgd多肽-氧化石墨烯复合纳米材料及其制备方法与应用
WO2023082212A1 (zh) * 2021-11-13 2023-05-19 广东暨创硒源纳米研究院有限公司 硒化锡纳米粒子复合物及其对肿瘤相关巨噬细胞的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012154885A2 (en) * 2011-05-09 2012-11-15 Visen Medical, Inc. Carbonic anhydrase targeting agents and methods of using same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600721A1 (de) 1996-01-12 1997-07-17 Hoechst Ag Verwendung von Inhibitoren des Carboanhydratase (CAH) zum Herstellen eines Medikaments zur Behandlung von Krebs
HUE028349T2 (en) 2002-11-26 2016-12-28 Inst Virology CAIX-specific inhibitors
NO20035681D0 (no) 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av lungekreft
WO2006137092A1 (en) 2005-06-23 2006-12-28 Supuran Claudiu T Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as theapeutic and diagnostic agents
EP1937851A4 (en) 2005-10-19 2010-08-25 Ibc Pharmaceuticals Inc METHOD AND COMPOSITIONS FOR PRODUCING BIOACTIVE GROUPS OF INCREASED COMPLEXITY AND THEIR USE
WO2008071421A1 (en) 2006-12-15 2008-06-19 Nicox S.A. Nitrate esters of carbonic anhydrase inhibitors
US8227204B2 (en) 2007-10-18 2012-07-24 The Invention Science Fund I, Llc Ionizing-radiation-responsive compositions, methods, and systems
WO2010069941A1 (en) 2008-12-16 2010-06-24 Fundació Privada Institut Català De Nanotecnologia Conjugates comprising nanoparticles coated with platinum containing compounds
EP2289528A1 (en) 2009-07-21 2011-03-02 DSM IP Assets B.V. Novel nutraceutical compositions containing black pepper or its constituents improving mental performance
US9138418B2 (en) 2009-12-09 2015-09-22 William Marsh Rice University Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles
CN103221388B (zh) 2010-07-09 2016-09-28 维理生物技术公司 用于抑制转移性肿瘤生长的新型磺酰胺化合物
US20120029062A1 (en) 2010-08-02 2012-02-02 Gunaratne Preethi H Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof
US11077212B2 (en) * 2010-08-24 2021-08-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Molecular imaging of cancer cells in vivo
CA2856812A1 (en) 2010-11-28 2012-05-31 Metasignal Therapeutics Inc. Carbonic anhydrase inhibitors with antimetastatic activity
WO2012175654A1 (en) 2011-06-23 2012-12-27 Facultes Universitaires Notre-Dame De La Paix Tetraline sulfonamide derivatives for use in the treatment of proliferative disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012154885A2 (en) * 2011-05-09 2012-11-15 Visen Medical, Inc. Carbonic anhydrase targeting agents and methods of using same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FULVIO RATTO ET AL: "Size and shape control in the overgrowth of gold nanorods", JOURNAL OF NANOPARTICLE RESEARCH ; AN INTERDISCIPLINARY FORUM FOR NANOSCALE SCIENCE AND TECHNOLOGY, KLUWER ACADEMIC PUBLISHERS, DO, vol. 12, no. 6, 24 July 2009 (2009-07-24), pages 2029 - 2036, XP019826965, ISSN: 1572-896X *
KEVIN GROVES ET AL: "Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, GB, vol. 22, no. 1, 18 October 2011 (2011-10-18), pages 653 - 657, XP028352398, ISSN: 0960-894X, [retrieved on 20111024], DOI: 10.1016/J.BMCL.2011.10.058 *
MAAMAR STITI ET AL: "Carbonic Anhydrase Inhibitor Coated Gold Nanoparticles Selectively Inhibit the Tumor-Associated Isoform IX over the Cytosolic Isozymes I and II", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 130, no. 48, 3 December 2008 (2008-12-03), pages 16130 - 16131, XP055086710, ISSN: 0002-7863, DOI: 10.1021/ja805558k *
N. K. TAFRESHI ET AL: "Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes", CLINICAL CANCER RESEARCH, vol. 18, no. 1, 20 October 2011 (2011-10-20), pages 207 - 219, XP055086887, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-11-0238 *

Also Published As

Publication number Publication date
WO2014136076A3 (en) 2014-11-20
US20160015661A1 (en) 2016-01-21
EP2964272A2 (en) 2016-01-13
WO2014136076A2 (en) 2014-09-12

Similar Documents

Publication Publication Date Title
FIC20230007I1 (fi) Valoktokogeeniroksaparvoveekki kaikissa peruspatentin suojaamissa muodoissa
ITRM20130138A1 (it) Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica
IL244294A0 (en) Prepared luminaire and related methods for controlling the light output
BR302013003119S1 (pt) Configuração aplicada a despertador com iluminação
EP3026587A4 (en) METHOD FOR DETERMINING THE LIFE OF COMPONENTS OF AN AIR GENERATOR OR THE LIKE ACCORDING TO THEIR LOCATION
CL2015002220A1 (es) Método y dispositivo para el pretratamiento de biomasa para la conversión a energía.
PL3087038T3 (pl) Sposób ciągłej hydrolizy termicznej osadu o wysokim wysuszeniu
ZA201600940B (en) Multi-cycle power generator
EP2985428A4 (en) COMBINED GAS TURBINE CYCLE INSTALLATION AND INSTALLATION ON THE SURFACE OF WATER
BR112015032322A2 (pt) dispositivo fotovoltaico e método para manufaturar o mesmo
FR3011912B1 (fr) Module economiseur d'energie
FI20165076A (fi) Menetelmä akun ylläpitämiseksi
DK3039286T3 (da) Vindturbine med indbygget strømforsyningsenhed
FR3009209B1 (fr) Biopile a combustible
GB201315257D0 (en) "Boudica" renewable energy engine/generator
CL2012002199A1 (es) Aparato que simula la orientación espacial de un edificio respecto del sol para estimar el area de captación solar directa, que comprende una plataforma con una maqueta de edificio, una estructura circular, un arco graduado, un arco con una unidad captadora de imagenes y un microprocesador para almacenarlas; y metodo asociado.
FR3010166B1 (fr) Transmission a variation continue avec recirculation de puissance
FR3010672B1 (fr) Ensemble d'absorption d'energie de choc
FR3001282B1 (fr) Dispositif de production d'energie electrique et chaleur thermodynamique autonome
BR302013002144S1 (pt) Configuração ornamental aplicada a assadeira
FR3011816B1 (fr) Train d'atterrissage a balancier et giravion
AP00562S1 (en) Portable led solar lantern
FI20145867A (fi) Otto-kaasumoottori
UA27205S (uk) Елетростанція газотурбінна
TH45016S1 (th) โคมไฟ